BIOGEN IDEC
Biogen Idec uses cutting-edge science to discover, develop, manufacture and market biological products for the treatment of serious diseases with a focus on neurological disorders. Founded in 1978, Biogen Idec is the world's oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates more than $4 billion in annual revenues.
BIOGEN IDEC
Social Links:
Industry:
Biotechnology Health Care Neuroscience Therapeutics
Founded:
1978-01-01
Address:
Weston, Massachusetts, United States
Country:
United States
Website Url:
http://www.biogen.com
Total Employee:
5001+
Status:
Active
Contact:
(781) 464-2000
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Content Delivery Network Domain Not Resolving Apache Mobile Non Scaleable Content Euro Organization Schema IPv6
Similar Organizations
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
MBF Bioscience
MBF Bioscience is a biotechnology firm that provides imaging software for stereology, neuron reconstruction, and image analysis.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2019-03-04 | Nightstar Therapeutics | Nightstar Therapeutics acquired by Biogen Idec | N/A |
2017-05-18 | Remedy Pharmaceuticals | Remedy Pharmaceuticals acquired by Biogen Idec | 120 M USD |
2015-01-11 | Convergence Pharmaceuticals | Convergence Pharmaceuticals acquired by Biogen Idec | 675 M USD |
2014-02-14 | Stromedix | Stromedix acquired by Biogen Idec | 75 M USD |
2013-02-01 | Tysabri | Tysabri acquired by Biogen Idec | N/A |
2007-01-04 | Syntonix Pharmaceuticals | Syntonix Pharmaceuticals acquired by Biogen Idec | 120 M USD |
2006-05-31 | Fumapharm | Fumapharm acquired by Biogen Idec | N/A |
2006-05-03 | Conforma Therapeutics | Conforma Therapeutics acquired by Biogen Idec | 150 M USD |
2003-06-24 | IDEC Pharmaceuticals | IDEC Pharmaceuticals acquired by Biogen Idec | 6.4 B USD |
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-09-08 | Autobahn Therapeutics | Biogen Idec investment in Venture Round - Autobahn Therapeutics | 32.7 M USD |
2020-11-27 | SAGE Therapeutics | Biogen Idec investment in Post-IPO Equity - SAGE Therapeutics | 650 M USD |
2020-06-11 | Autobahn Therapeutics | Biogen Idec investment in Series B - Autobahn Therapeutics | 76 M USD |
2020-01-13 | CAMP4 Therapeutics | Biogen Idec investment in Venture Round - CAMP4 Therapeutics | 15 M USD |
2018-06-28 | Samsung Bioepis | Biogen Idec investment in Venture Round - Samsung Bioepis | 748.6 B KRW |
2017-10-25 | Neurimmune Holding | Biogen Idec investment in Venture Round - Neurimmune Holding | 150 M USD |
2017-03-30 | Solid Biosciences | Biogen Idec investment in Series C - Solid Biosciences | 50 M USD |
2016-01-06 | Rodin Therapeutics | Biogen Idec investment in Series B - Rodin Therapeutics | 17.3 M USD |
2014-06-17 | True North Therapeutics | Biogen Idec investment in Series A - True North Therapeutics | 22 M USD |
2014-03-17 | Ataxion | Biogen Idec investment in Series A - Ataxion | 17 M USD |
Newest Events participated
Official Site Inspections
http://www.biogen.com
- Host name: ec2-52-72-21-39.compute-1.amazonaws.com
- IP address: 52.72.21.39
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149